Effects on gastrointestinal functions and symptoms of serotonergic psychoactive agents used in functional gastrointestinal diseases.
about
Efficacy of tandospirone in patients with irritable bowel syndrome-diarrhea and anxiety.Effect of clinician-patient communication on compliance with flupentixol-melitracen in functional dyspepsia patients.Pilot trial: pregabalin on colonic sensorimotor functions in irritable bowel syndrome.Treatment of abdominal pain in irritable bowel syndrome.Metabolic kinetics of 5-hydroxytryptamine and the research targets of functional gastrointestinal disorders.Visceral hypersensitivity and electromechanical dysfunction as therapeutic targets in pediatric functional dyspepsia.Treatment of functional dyspepsia and gastroparesis.Opioid misuse in gastroenterology and non-opioid management of abdominal pain.Acotiamide improves stress-induced impaired gastric accommodation.Potential rat model of anxiety-like gastric hypersensitivity induced by sequential stress.Serotonin Transporter Gene (SLC6A4) Polymorphism May Be Associated with Chinese Globus Pharyngeus and Its Antidepressant Effects.Evidence for PMAT- and OCT-like biogenic amine transporters in a probiotic strain of Lactobacillus: Implications for interkingdom communication within the microbiota-gut-brain axis.The role of inflammation in irritable bowel syndrome (IBS)A Meta-Analysis of the Clinical Use of Curcumin for Irritable Bowel Syndrome (IBS)
P2860
Q34093943-5F382C79-7B2A-4A97-B35C-B88051940146Q35473109-356FEC3F-A552-4E3E-8975-BC7557BD0FB4Q37624734-33047B0E-69FE-459E-9AB4-2578060968DEQ38213185-EE78362B-90EC-439D-8165-F89CDC9ED46EQ38219316-65593154-A508-4E93-AEA3-998AF1168550Q38240885-7C7927B0-FD9A-4F2B-87D3-E30AE00F1096Q38244400-BAC7847C-6DF0-4EFD-B39B-0A90D424D470Q44350905-610864CA-1640-46B0-A790-9D431B8C8A08Q46341120-5EEF1146-E2BA-4A99-A646-F405ED11CB5EQ47145380-05997992-2704-4345-BD54-30F886DE5480Q47647993-E69DC2CE-191D-4563-A0BB-1000D8970E3FQ47870073-D98EFF04-CA57-48D7-8EA1-6C2530ED1989Q57071273-BC1DB0FF-FD0D-455C-9920-41738C4B0952Q58702100-FFC44A8A-31C7-4D87-B9C7-2766BA85EE07
P2860
Effects on gastrointestinal functions and symptoms of serotonergic psychoactive agents used in functional gastrointestinal diseases.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Effects on gastrointestinal fu ...... nal gastrointestinal diseases.
@ast
Effects on gastrointestinal fu ...... nal gastrointestinal diseases.
@en
Effects on gastrointestinal fu ...... nal gastrointestinal diseases.
@nl
type
label
Effects on gastrointestinal fu ...... nal gastrointestinal diseases.
@ast
Effects on gastrointestinal fu ...... nal gastrointestinal diseases.
@en
Effects on gastrointestinal fu ...... nal gastrointestinal diseases.
@nl
prefLabel
Effects on gastrointestinal fu ...... nal gastrointestinal diseases.
@ast
Effects on gastrointestinal fu ...... nal gastrointestinal diseases.
@en
Effects on gastrointestinal fu ...... nal gastrointestinal diseases.
@nl
P2860
P1476
Effects on gastrointestinal fu ...... nal gastrointestinal diseases.
@en
P2093
Madhusudan Grover
P2860
P304
P356
10.1007/S00535-012-0726-5
P577
2012-12-20T00:00:00Z
2013-02-01T00:00:00Z